I agree that this site is using cookies. You can find further informations here.
X
Malet, I.
227  results:
Search for persons X
?
1

Surveillance de la résistance génomique aux antibiotiques d..:

Sanchez, A. ; Mayslich, C. ; Malet, I....
Annales de Dermatologie et de Vénéréologie.  147 (2020)  12 - p. A138 , 2020
Link: https://doi.org/10.1016/..
 
?
2

Phase 1 study of ceritinib in pediatric patients with malig..:

Fischer, M. ; Wulff, B. ; Baruchel, S....
European Journal of Cancer.  69 (2016)  - p. S49-S50 , 2016
Link: https://doi.org/10.1016/..
 
?
3

New Observer-Reported Outcomes To Measure Treatment Satisfa..:

Lasch, K. ; Horodniceanu, E.G. ; Carter, J.A....
Value in Health.  17 (2014)  7 - p. A534-A535 , 2014
Link: https://doi.org/10.1016/..
 
?
4

Comparative replication capacity of raltegravir-resistant s..:

Pollicita, M. ; Surdo, M. ; Di Santo, F....
Journal of Antimicrobial Chemotherapy.  69 (2014)  9 - p. 2412-2419 , 2014
Link: https://doi.org/10.1093/..
 
?
5

New raltegravir resistance pathways induce broad cross-resi..:

Malet, I. ; Gimferrer Arriaga, L. ; Artese, A....
Journal of Antimicrobial Chemotherapy.  69 (2014)  8 - p. 2118-2122 , 2014
Link: https://doi.org/10.1093/..
 
?
6

Highly multidrug-resistant HIV: clonal analysis and therape..:

Todesco, E. ; Sayon, S. ; Fourati, S....
Journal of Antimicrobial Chemotherapy.  68 (2013)  12 - p. 2882-2889 , 2013
Link: https://doi.org/10.1093/..
 
?
7

Genetic barrier to the development of resistance to rilpivi..:

Fofana, D. B. ; Soulie, C. ; Maiga, A. I....
Journal of Antimicrobial Chemotherapy.  68 (2013)  11 - p. 2515-2520 , 2013
Link: https://doi.org/10.1093/..
 
?
8

Risk factors for raltegravir resistance development in clin..:

Malet, I. ; Fourati, S. ; Morand-Joubert, L....
Journal of Antimicrobial Chemotherapy.  67 (2012)  10 - p. 2494-2500 , 2012
Link: https://doi.org/10.1093/..
 
?
9

HIV-1 genome is often defective in PBMCs and rectal tissues..:

Fourati, S. ; Lambert-Niclot, S. ; Soulie, C....
Journal of Antimicrobial Chemotherapy.  67 (2012)  10 - p. 2323-2326 , 2012
Link: https://doi.org/10.1093/..
 
?
10

Prevalence of resistance mutations related to integrase inh..:

Malet, I. ; Wirden, M. ; Fourati, S....
Journal of Antimicrobial Chemotherapy.  66 (2011)  7 - p. 1481-1483 , 2011
Link: https://doi.org/10.1093/..
 
?
11

The HIV-1 integrase G118R mutation confers raltegravir resi..:

Malet, I. ; Fourati, S. ; Charpentier, C....
Journal of Antimicrobial Chemotherapy.  66 (2011)  12 - p. 2827-2830 , 2011
Link: https://doi.org/10.1093/..
 
?
12

Factors associated with proviral DNA HIV-1 tropism in antir..:

Soulie, C. ; Fourati, S. ; Lambert-Niclot, S....
Journal of Antimicrobial Chemotherapy.  65 (2010)  4 - p. 749-751 , 2010
Link: https://doi.org/10.1093/..
 
?
13

Quasispecies variant dynamics during emergence of resistanc..:

Malet, I. ; Delelis, O. ; Soulie, C....
Journal of Antimicrobial Chemotherapy.  63 (2009)  4 - p. 795-804 , 2009
Link: https://doi.org/10.1093/..
 
?
14

Raltegravir has no residual antiviral activity in vivo agai..:

Wirden, M. ; Simon, A. ; Schneider, L....
Journal of Antimicrobial Chemotherapy.  64 (2009)  5 - p. 1087-1090 , 2009
Link: https://doi.org/10.1093/..
 
?
15

The G140S mutation in HIV integrases from raltegravir-resis..:

Delelis, O. ; Malet, I. ; Na, L....
Nucleic Acids Research.  37 (2008)  4 - p. 1193-1201 , 2008
Link: https://doi.org/10.1093/..
 
1-15